REVIEW
|
doi:10.20944/preprints202201.0265.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
CRISPR; gene editing; Duchenne muscular dystrophy (DMD); exon skipping; NHEJ; dystrophin
Online: 18 January 2022 (17:30:37 CET)
REVIEW
|
doi:10.20944/preprints202003.0048.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Duchenne muscular dystrophy; CRISPR; animal models; in vivo testing; dystrophin; mutant generation
Online: 4 March 2020 (04:58:48 CET)
REVIEW
|
doi:10.20944/preprints202407.0141.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
caveolae; caveolin; NOS; Duchenne muscular dystrophy; limb-girdle muscular dystrophy; gut microbiota; probiotics
Online: 2 July 2024 (08:18:55 CEST)
ARTICLE
|
doi:10.20944/preprints202406.0333.v1
Subject:
Medicine And Pharmacology,
Pediatrics, Perinatology And Child Health
Keywords:
Duchenne muscular dystrophy; sniff nasal inspiratory pressure; supine spirometry; diaphragm
Online: 6 June 2024 (07:44:26 CEST)
REVIEW
|
doi:10.20944/preprints202405.0015.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Duchenne muscular dystrophy; cardiomyopathy; inflammation; skeletal muscle; adiponectin
Online: 1 May 2024 (07:27:08 CEST)
REVIEW
|
doi:10.20944/preprints202010.0234.v1
Subject:
Medicine And Pharmacology,
Clinical Medicine
Keywords:
myostatin inhibition; Duchenne Muscular Dystrophy; skeletal muscle; muscle development; clinical trials; translation
Online: 12 October 2020 (12:07:43 CEST)
REVIEW
|
doi:10.20944/preprints201811.0018.v1
Subject:
Biology And Life Sciences,
Biochemistry And Molecular Biology
Keywords:
Duchenne muscular dystrophy (DMD); CRISPR/Cas9; exon skipping therapy; gene editing; human induced pluripotent stem cells (hiPSCs); immortalized patient muscle cells; mdx mice; humanized dystrophic mouse models; deltaE50-MD dog model
Online: 2 November 2018 (05:14:23 CET)
CASE REPORT
|
doi:10.20944/preprints202404.0620.v1
Subject:
Biology And Life Sciences,
Other
Keywords:
Duchenne muscular dystrophy; Balance; Gower’ s sign; Rehabilitation; Physiotherapy; Dynamic neuromuscular stabilization
Online: 9 April 2024 (08:53:39 CEST)
REVIEW
|
doi:10.20944/preprints202306.2170.v1
Subject:
Medicine And Pharmacology,
Neuroscience And Neurology
Keywords:
N-acetylcysteine; amino acid supplements; L-arginine; Duchenne muscular dystrophy; mdx mouse; osmolytes; supportive therapy; taurine
Online: 30 June 2023 (07:13:00 CEST)
SHORT NOTE
|
doi:10.20944/preprints202407.1124.v1
Subject:
Medicine And Pharmacology,
Other
Keywords:
DIPA-CRISPR; Cockroach; insects; gene editing; Duchenne Muscular Dystrophy
Online: 15 July 2024 (04:53:50 CEST)
REVIEW
|
doi:10.20944/preprints202403.0880.v1
Subject:
Biology And Life Sciences,
Biology And Biotechnology
Keywords:
Chromosome Transplantation; Genomic Disease; X Chromosome; Duchenne Muscular Dystrophy; iPSC
Online: 15 March 2024 (10:10:00 CET)
ARTICLE
|
doi:10.20944/preprints202407.0952.v1
Subject:
Social Sciences,
Cognitive Science
Keywords:
cooperativeness; personality trait; Duchenne smile; gaze; cooperation; communication; fNIRS; inter-brain synchrony
Online: 12 July 2024 (04:17:56 CEST)
ARTICLE
|
doi:10.20944/preprints202309.0417.v1
Subject:
Medicine And Pharmacology,
Pharmacology And Toxicology
Keywords:
adenylosuccinic acid; Duchenne muscular dystrophy; myopathy; metabolic disease; skeletal muscle; toxicology; drug development
Online: 7 September 2023 (05:09:43 CEST)
REVIEW
|
doi:10.20944/preprints202012.0441.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
dystrohinopathy; Duchenne muscular disease; Becker muscular disease; dystrophic deficient cardiomyopathy; cardiac fibrosis; renin angiotensin system; angiotensin 2; angiotensin converter enzyme inhibitors; angiotensin receptor blockers; heart failure
Online: 18 December 2020 (07:18:16 CET)
REVIEW
|
doi:10.20944/preprints201912.0385.v1
Subject:
Medicine And Pharmacology,
Cardiac And Cardiovascular Systems
Keywords:
dilated cardiomyopathy (DCM); hypertrophic cardiomyopathy (HCM); restrictive cardiomyopathy (RCM); arrhythmogenic right ventricular cardiomyopathy (ARVC); left ventricular non-compaction cardiomyopathy (LVNC); Duchenne muscular dystrophy; dystrophin; genome editing; CRISPR/Cas9; Cpf1 (Cas12a)
Online: 29 December 2019 (13:41:48 CET)